BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

971 related articles for article (PubMed ID: 8915780)

  • 1. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of IGF-I, alone and in combination with 17 beta-oestradiol, on bone remodelling parameters in ovariectomised rats.
    Verhaeghe J; Van Herck E; van Bree R; Bouillon R
    Growth Regul; 1995 Dec; 5(4):210-7. PubMed ID: 8745147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F; Lang K; Dony C; Kling L
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
    Narusawa K; Nakamura T; Suzuki K; Matsuoka Y; Lee LJ; Tanaka H; Seino Y
    J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats.
    Fuse H; Fukumoto S; Sone H; Miyata Y; Saito T; Nakayama K; Takahashi H; Matsumoto T; Ogata E
    J Bone Miner Res; 1997 Apr; 12(4):590-7. PubMed ID: 9101370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.
    Jiang Y; Zhao J; Genant HK; Dequeker J; Geusens P
    J Bone Miner Res; 1997 May; 12(5):820-31. PubMed ID: 9144349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
    Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
    J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ovariectomy and ovarian steroid treatment on growth hormone and insulin-like growth factor-I levels in the rat femur.
    Suliman IA; El-Bakri NK; Adem A; Mustafa A; Lindgren JU
    J Orthop Res; 2001 Nov; 19(6):1008-12. PubMed ID: 11780998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats.
    Andreassen TT; Oxlund H
    J Bone Miner Res; 2000 Nov; 15(11):2266-75. PubMed ID: 11092409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats.
    Verhaeghe J; Suiker AM; Einhorn TA; Geusens P; Visser WJ; Van Herck E; Van Bree R; Magitsky S; Bouillon R
    J Bone Miner Res; 1994 Oct; 9(10):1657-67. PubMed ID: 7817814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
    Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
    J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term diabetes and/or high-dose 17 beta-estradiol on bone formation, bone mineral density, and strength in ovariectomized rats.
    Verhaeghe J; Oloumi G; van Herck E; van Bree R; Dequeker J; Einhorn TA; Bouillon R
    Bone; 1997 May; 20(5):421-8. PubMed ID: 9145239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of exercise and propranolol on bone tissue in ovariectomized rats.
    Bonnet N; Beaupied H; Vico L; Dolleans E; Laroche N; Courteix D; Benhamou CL
    J Bone Miner Res; 2007 Apr; 22(4):578-88. PubMed ID: 17243867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
    Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
    J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for involvement of 17beta-estradiol in intestinal calcium absorption independent of 1,25-dihydroxyvitamin D3 level in the Rat.
    Colin EM; Van Den Bemd GJ; Van Aken M; Christakos S; De Jonge HR; Deluca HF; Prahl JM; Birkenhäger JC; Buurman CJ; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1999 Jan; 14(1):57-64. PubMed ID: 9893066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.